Literature DB >> 3763813

Bone and mineral metabolism and chronic alcohol abuse.

B C Lalor, M W France, D Powell, P H Adams, T B Counihan.   

Abstract

Studies of bone and mineral metabolism were made in 22 patients with chronic alcohol abuse and varying degrees of liver damage. None of the patients had clinical evidence of metabolic bone disease, but quantitative bone histology showed that six had osteoporosis, three osteomalacia, and two osteoporosis and osteomalacia combined. Trabecular bone volume (TBV) tended to be reduced in relation to age, and there was histological evidence of reduced bone formation particularly among the patients with osteoporosis. Multivariate analysis of the relevant variables showed that the major determinants of age-adjusted trabecular bone volume were the serum concentration of albumin and the dietary calcium. The presence of osteoporosis was related to the state of liver function and the type of alcohol habitually consumed, and was a particular feature of patients with severe liver disease and those who only drank spirits. Six patients (five with osteoporosis) had biochemical evidence of hyperparathyroidism, but none showed histological evidence of increased bone resorption or of osteitis fibrosa. In four patients the development of hyperparathyroidism was probably related to underlying magnesium deficiency. Serum calcidiol tended to be reduced and was directly related to the state of liver function; four patients had reduced or low normal serum concentrations of calcitriol. In only three patients could the development of osteomalacia be related to vitamin D deficiency; in two patients the cause of the osteomalacia was obscure. Significant changes in bone structure and mass appear to be common among heavy drinkers even in the absence of clinical metabolic bone disease. These skeletal abnormalities are likely to be relevant to the increased fracture risk associated with heavy drinking.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763813

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  20 in total

1.  Guidelines on the management of osteoporosis associated with chronic liver disease.

Authors:  Jane D Collier; M Ninkovic; J E Compston
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Alcoholism-associated spinal and femoral bone loss in abstinent male alcoholics, as measured by dual X-ray absorptiometry.

Authors:  K S Chon; D J Sartoris; S A Brown; P Clopton
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 3.  Strategies for prevention of osteoporosis and hip fracture.

Authors:  M R Law; N J Wald; T W Meade
Journal:  BMJ       Date:  1991-08-24

Review 4.  Osteoporosis: cause and management.

Authors:  R Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

Review 5.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

6.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

7.  Bone mineral density measured by dual-energy X-ray absorptiometry in healthy Finnish women.

Authors:  K Laitinen; M Välimäki; P Keto
Journal:  Calcif Tissue Int       Date:  1991-04       Impact factor: 4.333

8.  Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery.

Authors:  M Kathleen Clark; Mary Fran R Sowers; Farideh Dekordi; Sara Nichols
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

Review 9.  Association between alcohol consumption and both osteoporotic fracture and bone density.

Authors:  Karina M Berg; Hillary V Kunins; Jeffrey L Jackson; Shadi Nahvi; Amina Chaudhry; Kenneth A Harris; Rubina Malik; Julia H Arnsten
Journal:  Am J Med       Date:  2008-05       Impact factor: 4.965

Review 10.  Alcohol and bone.

Authors:  K Laitinen; M Välimäki
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.